Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B3 | P37058 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | CDK4 | P11802 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | CCND1 | P24385 | 1/20 | 0.35 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.35 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.35 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.34 |
| ▸ | KDM1A | O60341 | 1/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | BRD4 | O60885 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL1780078 | 1.00 | HSD17B3 (0.39) | HSD17B3MEN1ALDH1A1KMT2AUSP2 | |
| Iodide SCHEMBL2821259 | 1.00 | HSD17B3 (0.39) | HSD17B3MEN1ALDH1A1KMT2AUSP2 | |
| SCHEMBL927716 | 0.97 | HSD17B3 (0.40) | HSD17B3MEN1ALDH1A1KMT2AUSP2 | |
| Hydrochloric Acid SCHEMBL30935728 | 0.95 | MEN1 (0.40) | HSD17B3MEN1ALDH1A1KMT2AUSP2 | |
| SCHEMBL1780083 | 0.89 | HSD17B3 (0.36) | HSD17B3MEN1ALDH1A1KMT2AUSP2 | |
| Bicarbonate SCHEMBL26677806 | 0.87 | BRD4 (0.44) | MEN1KMT2AMTNR1AMTNR1BPOLB | |
| Iodide SCHEMBL9327210 | 0.87 | ALDH1A1 (0.41) | HSD17B3MEN1ALDH1A1KMT2AUSP2 | |
| SCHEMBL9330383 | 0.87 | MEN1 (0.47) | HSD17B3MEN1ALDH1A1KMT2AUSP2 | |
| Bromide SCHEMBL9328394 | 0.85 | MEN1 (0.46) | HSD17B3MEN1ALDH1A1KMT2AUSP2 | |
| SCHEMBL30463973 | 0.84 | ALDH1A1 (0.42) | HSD17B3MEN1ALDH1A1KMT2AUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2377535-A1 | METHOD AND COMPOSITION FOR TREATING MULTIPLE SCLEROSIS (VARIANTS) | Averin, Konstantin Mihailovich (RU) | 2011-10-19 | — | — | EP | claimed |
| US-20110118324-A1 | METHOD AND COMPOSITION FOR TREATING MULTIPLE SCLEROSIS (VARIANTS) | Stradomskiy, Boris Vitalyevich (RU) | 2011-05-19 | — | — | US | claimed |
| US-20100286216-A1 | COMPOSITION HAVING A HIGH OSMOTIC ACTIVITY AND EXHIBITING ANTIMICROBIAL, ANTI-INFLAMMATORY, AND REGENERATIVE EFFECTS | Boris Vitalyevich STRADOMSKIY | 2010-11-11 | — | — | US | claimed |
| CN-110198721-B | Antibacterial composition containing polyvinylpyrrolidone and sodium dimercaptopropanesulfonate and application thereof | 梅迪德创新研发有限公司 | 2022-06-07 | — | — | CN | disclosed |
| EP-3585399-B1 | ANTISEPTIC COMPOSITION COMPRISING POLYVINYLPYRROLIDONE AND UNITHIOL AND USE OF THE COMPOSITION | MEDID INNOVATION DEV LTD (CY) | 2022-02-09 | — | — | EP | disclosed |
| US-11045551-B2 | Antiseptic composition comprising polyvinylpyrrolidone and unithiol and use of the composition | Medid Innovation Development Ltd (CY) | 2021-06-29 | — | — | US | disclosed |
| EP-3006020-B1 | METHOD FOR TREATING RECURRING SKIN AND MUCOUS MEMBRANE DISEASES CAUSED BY HSV-1 AND HSV-2 | TETS VIKTOR VENIAMINOVICH (RU) | 2020-06-24 | — | — | EP | disclosed |
| WO-2018156051-A1 | ANTISEPTIC COMPOSITION COMPRISING POLYVINYLPYRROLIDONE AND UNITHIOL AND USE OF THE COMPOSITION | OBSHCHESTVO S OGRANICHENNOJ OTVETSTVENNOST`YU "WDS" (RU) | 2018-08-30 | — | — | WO | disclosed |
| EP-3006020-A1 | METHOD FOR TREATING RECURRING SKIN AND MUCOUS MEMBRANE DISEASES CAUSED BY HSV-1 AND HSV-2 | Tets, Viktor Veniaminovich (RU) | 2016-04-13 | — | — | EP | disclosed |
| EP-2377535-A1 | METHOD AND COMPOSITION FOR TREATING MULTIPLE SCLEROSIS (VARIANTS) | Averin, Konstantin Mihailovich (RU) | 2011-10-19 | — | — | EP | disclosed |
| EP-2377535-A1 | METHOD AND COMPOSITION FOR TREATING MULTIPLE SCLEROSIS (VARIANTS) | Averin, Konstantin Mihailovich (RU) | 2011-10-19 | — | — | EP | disclosed |
| US-20110118324-A1 | METHOD AND COMPOSITION FOR TREATING MULTIPLE SCLEROSIS (VARIANTS) | Stradomskiy, Boris Vitalyevich (RU) | 2011-05-19 | — | — | US | disclosed |
| US-20110118324-A1 | METHOD AND COMPOSITION FOR TREATING MULTIPLE SCLEROSIS (VARIANTS) | Stradomskiy, Boris Vitalyevich (RU) | 2011-05-19 | — | — | US | disclosed |
| US-20100286216-A1 | COMPOSITION HAVING A HIGH OSMOTIC ACTIVITY AND EXHIBITING ANTIMICROBIAL, ANTI-INFLAMMATORY, AND REGENERATIVE EFFECTS | Boris Vitalyevich STRADOMSKIY | 2010-11-11 | — | — | US | disclosed |
| US-20100286216-A1 | COMPOSITION HAVING A HIGH OSMOTIC ACTIVITY AND EXHIBITING ANTIMICROBIAL, ANTI-INFLAMMATORY, AND REGENERATIVE EFFECTS | Boris Vitalyevich STRADOMSKIY | 2010-11-11 | — | — | US | disclosed |
| WO-2010082863-A1 | METHOD AND COMPOSITION FOR TREATING MULTIPLE SCLEROSIS (VARIANTS) | АВЕРИН, Константин Михайлович (RU) | 2010-07-22 | — | — | WO | disclosed |
| WO-2009084975-A8 | COMPOSITION EXHIBITING HIGH OSMOTIC ANTIMICROBIAL, ANTI-INFLAMMATORY AND REGENERATION ACTIVITY | АВЕРИН, Константин Михайлович (RU) | 2009-10-22 | — | — | WO | disclosed |
| WO-2009084975-A1 | COMPOSITION EXHIBITING HIGH OSMOTIC ANTIMICROBIAL, ANTI-INFLAMMATORY AND REGENERATION ACTIVITY | AVERIN, KONSTANTIN MIHAILOVICH (RU) | 2009-07-09 | — | — | WO | disclosed |
| WO-2005110002-A3 | ANTI-INFLAMMATORY AND ANTICEPTIC SUPPOSITORY EXHIBITING A REGENERATION EFFECT | AVERIN KONSTANTIN MIHAILOVICH (RU) | 2006-01-26 | — | — | WO | disclosed |
| WO-2005110002-A2 | ANTI-INFLAMMATORY AND ANTICEPTIC SUPPOSITORY EXHIBITING A REGENERATION EFFECT | AVERIN, KONSTANTIN MIHAILOVICH (RU) | 2005-11-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11045551-B2 | Antiseptic composition comprising polyvinylpyrrolidone and unithiol and use of the composition | PUF60, USP47, UBAP2L | HSD17B3 3144/4885MEN1 4239/4885ALDH1A1 1228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.